Omar Makram Elsayed, MD MPH (Omar M Makram)
@OelsayedMD
Followers
1K
Following
1K
Media
15
Statuses
264
IM @MCG_InternalMed | @AHAScience #SFRN CardioOnc fellow 🫀| MPH @LSHTM 🇬🇧 | MSc @gtomsanalytics 🐝 I Postdoc @MethodistHosp | MD 🇪🇬 |#Epidemiology #Data
Augusta, GA
Joined March 2022
New in JNCI Cancer Spectrum‼️ Socioeconomic position (SEP) meaningfully predicts cardiovascular🫀 (CV) outcomes in men with #prostate_cancer. We examined how neighborhood disadvantage shapes long-term CV and survival risks #cardiooncology #CancerResearch
https://t.co/68G6lZ6Bxk
3
3
8
Presentation #5 on last day of #AHA25 by @dukemedicine #SarahMalik from @MCG_AUG - Take home - In 12,832 #ARIC participants followed for 28 years, 877 cancer survivors and 3,653 non-cancer participants developed incident CVD. Across both unmatched and propensity-matched analyses,
#AHA25 #CardioOncology Excited to highlight our lab’s #ARIC-cancer work by Dr. Sarah Malik and team: “The Use of Common Cardiovascular Medications Is Associated with a Comparable Decrease in CVD Risk in Cancer Survivors and Non-Cancer Patients.” Join her moderated presentation on
1
4
13
Final (#6) presentation of #AHA25 by @MCG_AUG student @sathvika_n focused on disparities in clinical trials - take home - Among 284 Southern U.S. cities, only 26% contained a Phase III lipid-lowering trial site, with a median drive time of 36 minutes to the nearest site. Each
#AHA25 Excited to present our work from @MCG_AUG with my team: “Unequal Access: Socioeconomic Deprivation & Travel Distance to Phase III Lipid-Lowering Trials in the Southern U.S.” Join me for my moderated poster session on Mon, Nov 10 (2:06–2:11 PM CT, Population Science Zone)!
1
6
9
🌟 What an incredible experience presenting at #AHA25! 🎤 Honored to share our collaborative work with Memorial Sloan Kettering—advancing risk prediction in HER2+ breast cancer under the mentorship of @anita_deswal 💙🫀 Grateful for the journey & teamwork #CardioOncology
5
9
24
🎬 Grateful for the opportunity to join Dr. Fred Kusumoto in providing #AHA25 coverage with @ACCinTouch 💙We discussed standout trials from Day 2️⃣ & previewed upcoming #HeartFailure studies, including POLY-HF & CAVIAR 🫀✨#CardioTwitter
#AHA25: Drs. Fred M. Kusumoto & Abdelrahman Ali discuss the standout trials from Day 2️⃣ & share what they’re looking forward to in upcoming HF studies, including POLY-HF & CAVIAR. 🔗 https://t.co/TUxgjPD5bZ
@Abdelcards #ACCAnywhere #CardioX
0
8
23
Second presentation for the day by superstar @virajshahr - take home - Among 3,192 African American ARIC participants followed for 22.4 years, 30% developed cancer. The DARC-positive genotype was not significantly associated with overall, smoking-related, or obesity-related
Come, check out our work funded by @AHAScience #SFRN. Learn about role of ancestral gene ACKR1 and how that changes cancer risk in those with cardiovascular disease. Previously we had shown the role of neutrophil to lymphocyte ratio. We were fortunate to collaborate with.@MeliD32
0
7
14
Thrilled to present our new abstract at #AHA25! 🫀 We compared traditional (BMI> 30) vs. new (BMI> 25 + central adiposity) #obesity definitions in the ARIC study (25-yr follow-up). Key Results: ✅ The new definition found a large, intermediate-risk group for CVD (aHR 1.25).
Third moderated poster by @OelsayedMD presenting moderated digital poster - take home #1 Among 14,834 ARIC participants followed for 25 years, 54% were classified as obese by the newer central adiposity definition versus 27% by the traditional BMI-based definition. The newly
1
1
14
Third moderated poster by @OelsayedMD presenting moderated digital poster - take home #1 Among 14,834 ARIC participants followed for 25 years, 54% were classified as obese by the newer central adiposity definition versus 27% by the traditional BMI-based definition. The newly
Obesity is an important overlap between cancer and cardiovascular disease. We talk about it here: https://t.co/1UXtFpAGas. How does the new WHO definition: https://t.co/M4SKpLcDxm of obesity shake up this risk factor- come and learn from @OelsayedMD at #AHA25 @AHAScience
1
5
13
On the eve of #AHA25, I am happy to report a new paper from our lab looking to replace CHADSVASC for AF in breast cancer. Published in @Cancers_MDPI - BS2CALED - In breast cancer + AF, B‑S2CALED predicts stroke/TIA better than CHA2DS2‑VASc and is externally validated. Simple 0–10
1
11
27
Why use this calculator? CHA2DS2‑VASc underperforms in cancer. B‑S2CALED improves discrimination (C‑index 0.64 vs 0.54 internal; 0.77 vs 0.53 external) + reclassification, with 3 tiers (0 none, 1–4 low/intermediate, >4 high). #CardioOncology #BreastCancer @ICOSociety @datsunian
0
3
6
Find us #AHA25 (CT): Sun 11/9 11:57–12:02 @adibhave1357 HER2 ADC cardiotoxicity ( Mod poster and @JAMANetworkOpen simpub) 3:15–3:20 @OelsayedMD obesity cancer/cvd (#11 Mod post) 3:15 @VirajShahr ACKR1/DARC (post) 3:50–3:55 @TarekNahle BrCa SEER (#10 Mod poster) @ICOSociety
1
7
19
Excellent disparities work in access to modern lipid lowering trials by M1 at @MCG_AUG @sathvika_n . Inspired by an unexplained denial to an oral PCSK9 phase 3 trial, we wondered what happens when ultra modern medicine is not available to large number of patients due to biased
#AHA25 Excited to present our work from @MCG_AUG with my team: “Unequal Access: Socioeconomic Deprivation & Travel Distance to Phase III Lipid-Lowering Trials in the Southern U.S.” Join me for my moderated poster session on Mon, Nov 10 (2:06–2:11 PM CT, Population Science Zone)!
0
2
7
Obesity is an important overlap between cancer and cardiovascular disease. We talk about it here: https://t.co/1UXtFpAGas. How does the new WHO definition: https://t.co/M4SKpLcDxm of obesity shake up this risk factor- come and learn from @OelsayedMD at #AHA25 @AHAScience
thelancet.com
Despite evidence that some people with excess adiposity have ill health due to obesity, obesity is generally considered a harbinger of other diseases, not a disease in itself.
Nov 9th, 3:15 P.M. at #AHA25: Join Dr. Omar Elsayed from @AUG_University/@WellstarHealth for the moderated poster presentation, “Comparing Traditional and Newer Definitions of Obesity in Relation to Incident Cardiovascular Disease and Cancer Risk: A Prospective Cohort Study.”
0
5
16
@TarekNahle @AUG_University @WellstarHealth @avirupguha @virajshahr @OelsayedMD @sdent_cardioonc @husam247 @neerajaiims We would like to inform you that your post has been published on https://t.co/igx4msE1Ge. Thank you for sharing. https://t.co/wRD9UCM0UT
oncodaily.com
Tarek Nahle: Augusta University Study on Cardiovascular Mortality in Breast Cancer at AHA 2025 / Breast Cancer, cancer, CardioOncology, OncoDaily, Oncology,
0
2
3
Happening on Nov 9th: "Evaluating the Cardiotoxicity of Novel Antibody Drug Conjugates vs Standard of Care for HER2+ Metastatic Breast Cancer: A Single-Arm Meta-Analysis" 📍Clinical Science Zone 2 #BreastCancer #Cardiology
https://t.co/D3FydvqKps
@WellstarHealth @AUG_University
1
3
9
Nov 9th, 3:15 P.M. at #AHA25: Join Dr. Omar Elsayed from @AUG_University/@WellstarHealth for the moderated poster presentation, “Comparing Traditional and Newer Definitions of Obesity in Relation to Incident Cardiovascular Disease and Cancer Risk: A Prospective Cohort Study.”
1
3
12
Come, check out our work funded by @AHAScience #SFRN. Learn about role of ancestral gene ACKR1 and how that changes cancer risk in those with cardiovascular disease. Previously we had shown the role of neutrophil to lymphocyte ratio. We were fortunate to collaborate with.@MeliD32
ahajournals.org
Background: Both cancer and cardiovascular disease (CVD) are the leading causes of death worldwide. While previous research showed a relationship between CVD and cancer incidence, limited evidence is...
#AHA25 #DARC Check out our #ARIC-cancer study by @OelsayedMD, me, and our team: “Association of ACKR1 Genotype with Cancer Risk in Participants with African Ancestry in the ARIC Study.” Join us near our poster for a discussion on DARC in #Cardiooncology, presented by me on Sun,
0
7
13
#AHA25 #DARC Check out our #ARIC-cancer study by @OelsayedMD, me, and our team: “Association of ACKR1 Genotype with Cancer Risk in Participants with African Ancestry in the ARIC Study.” Join us near our poster for a discussion on DARC in #Cardiooncology, presented by me on Sun,
0
5
8
Excited to share an @AUG_University/@WellstarHealth study at #AHA25. Join us for the presentation, “Treatment Modality and Cardiovascular Mortality in Breast Cancer: A SEER & Single-Center Analysis by Stage & Receptor Subtype” on November 9th 🔗 https://t.co/qFf25VatWf
3
4
8